Reported Late Monday, PAVmed Q1 2024 Adj EPS $(0.99) Beats $(1.67) Estimate, Sales $1.010M Miss $1.053M Estimate
Reported Late Monday, PAVmed Q1 2024 Adj EPS $(0.99) Beats $(1.67) Estimate, Sales $1.010M Miss $1.053M Estimate
周一晚间公布，PAVMed2024年第一季度经调整后每股收益美元（0.99美元）超过预期（1.67美元），销售额为10.1亿美元，低于10.53万美元的预期
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.99) per share which beat the analyst consensus estimate of $(1.67) by 40.72 percent. This is a 42.77 percent increase over losses of $(1.73) per share from the same period last year. The company reported quarterly sales of $1.010 million which missed the analyst consensus estimate of $1.053 million by 4.06 percent. This is a 126.46 percent increase over sales of $446.000 thousand the same period last year.
PAVMed（纳斯达克股票代码：PAVM）公布的季度亏损为每股0.99美元，比分析师普遍预期的1.67美元（1.67美元）高出40.72个百分点。与去年同期每股亏损1.73美元（1.73）相比，增长了42.77％。该公司公布的季度销售额为10.1亿美元，比分析师普遍预期的10.53亿美元低4.06％。这比去年同期的44.6万美元销售额增长了126.46％。
资讯热榜
更新时间